Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review)
- Authors:
- Yufeng Li
- Yuhang Li
- Yinghui Song
- Sulai Liu
-
Affiliations: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R. China, Central Laboratory of Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, P.R. China - Published online on: February 2, 2024 https://doi.org/10.3892/or.2024.8712
- Article Number: 53
This article is mentioned in:
Abstract
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK and Gores GJ: Cholangiocarcinoma-evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 15:95–111. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Song Y, Cai M, Li Y and Liu S: The focus clinical research in intrahepatic cholangiocarcinoma. Eur J Med Res. 27:1162022. View Article : Google Scholar : PubMed/NCBI | |
|
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Everhart JE and Ruhl CE: Burden of digestive diseases in the United States part III: Liver, biliary tract, and pancreas. Gastroenterology. 136:1134–1144. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, et al: Guidelines for the diagnosis and treatment of cholangiocarcinoma: An update. Gut. 61:1657–1669. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Song Y and Liu S: The new insight of treatment in Cholangiocarcinoma. J Cancer. 13:450–464. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Valero V III, Cosgrove D, Herman JM and Pawlik TM: Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol. 6:481–495. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Glazer ES, Liu P, Abdalla EK, Vauthey JN and Curley SA: Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg. 16:1666–16671. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, et al: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 362:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dolmans DE, Fukumura D and Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
McCaughan JS Jr, Mertens BF, Cho C, Barabash RD and Payton HW: Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg. 126:111–113. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, Seo DW, Pantongrag-Brown L, Sangchan A, Pisespongsa P, et al: Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 28:593–607. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, et al: Photodynamic therapy of cancer: An update. CA Cancer J Clin. 61:250–281. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Baptista MS, Cadet J, Di Mascio P, Ghogare AA, Greer A, Hamblin MR, Lorente C, Nunez SC, Ribeiro MS, Thomas AH, et al: Type I and type II guidelines and mechanistic pathways. Photochem Photobiol. 93:912–919. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Castano AP, Mroz P and Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 6:535–545. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen B, Roskams T and de Witte PA: Antivascular tumor eradication by hypericin-mediated photodynamic therapy. Photochem Photobiol. 76:509–513. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Maharjan PS and Bhattarai HK: Singlet oxygen, photodynamic therapy, and mechanisms of cancer cell death. J Oncol. 2022:72114852022. View Article : Google Scholar : PubMed/NCBI | |
|
Brown SB, Brown EA and Walker I: The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5:497–508. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yanovsky RL, Bartenstein DW, Rogers GS, Isakoff SJ and Chen ST: Photodynamic therapy for solid tumors: A review of the literature. Photodermatol Photoimmunol Photomed. 35:295–303. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lucky SS, Soo KC and Zhang Y: Nanoparticles in photodynamic therapy. Chem Rev. 115:1990–2042. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fan W, Huang and Chen X: Overcoming the Achilles' heel of photodynamic therapy. Chem Soc Rev. 45:6488–6519. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hu F, Xu S and Liu B: Photosensitizers with aggregation-induced emission: Materials and biomedical applications. Adv Mater. 30:e18013502018. View Article : Google Scholar : PubMed/NCBI | |
|
Mroz P, Yaroslavsky A, Kharkwal GB and Hamblin MR: Cell death pathways in photodynamic therapy of cancer. Cancers (Basel). 3:2516–2539. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Jiang C, Longo JP, Azevedo RB, Zhang H and Muehlmann LA: An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B. 8:137–146. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kniebuhler G, Pongratz T, Betz CS, Göke B, Sroka R, Stepp H and Schirra J: Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)). Photodiagnosis Photodyn Ther. 10:220–228. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wagner A, Denzer UW, Neureiter D, Kiesslich T, Puespoeck A, Rauws EA, Emmanuel K, Degenhardt N, Frick U, Beuers U, et al: Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study. Hepatology. 62:1456–1465. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mattioli EJ, Ulfo L, Marconi A, Pellicioni V, Costantini PE, Marforio TD, Di Giosia M, Danielli A, Fimognari C, Turrini E and Calvaresi M: Carrying temoporfin with human serum albumin: A new perspective for photodynamic application in head and neck cancer. Biomolecules. 13:682022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen K, Yin B, Luo Q, Liu Y, Wang Y, Liao Y, Li Y, Chen X, Sun B, Zhou N, et al: Endoscopically guided interventional photodynamic therapy for orthotopic pancreatic ductal adenocarcinoma based on NIR-II fluorescent nanoparticles. Theranostics. 13:4469–4481. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Stein NC, Mulac D, Fabian J, Herrmann FC and Langer K: Nanoparticle albumin-bound mTHPC for photodynamic therapy: Preparation and comprehensive characterization of a promising drug delivery system. Int J Pharm. 582:1193472020. View Article : Google Scholar : PubMed/NCBI | |
|
Grunebaum J, Söbbing J, Mulac D and Langer K: Nanoparticulate carriers for photodynamic therapy of cholangiocarcinoma: In vitro comparison of various polymer-based nanoparticles. Int J Pharm. 496:942–952. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kurokawa H, Ito H and Matsui H: Porphylipoprotein accumulation and porphylipoprotein photodynamic therapy effects involving cancer cell-specific cytotoxicity. Int J Mol Sci. 22:73062021. View Article : Google Scholar : PubMed/NCBI | |
|
Dias LM, de Keijzer MJ, Ernst D, Sharifi F, de Klerk DJ, Kleijn TG, Desclos E, Kochan JA, de Haan LR, Franchi LP, et al: Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy. J Photochem Photobiol B. 234:1125002022. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng B, Zhong D, Xi T, Zhou J, Li W, Ilya A, Lu Y, Zhou M and Deng R: Near-infrared photosensitization via direct triplet energy transfer from lanthanide nanoparticles. Chem. 7:1615–1625. 2021. View Article : Google Scholar | |
|
Lu K, He C and Lin W: Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc. 136:16712–1675. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Alves SR, Calori IR and Tedesco AC: Photosensitizer-based metal-organic frameworks for highly effective photodynamic therapy. Mater Sci Eng C Mater Biol Appl. 131:1125142021. View Article : Google Scholar : PubMed/NCBI | |
|
Oleinick NL and Evans HH: The photobiology of photodynamic therapy: Cellular targets and mechanisms. Radiat Res. 150 (5 Suppl):S146–S156. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR and Oleinick NL: Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51:5993–5996. 1991.PubMed/NCBI | |
|
He JL, Guo MT, Tang L, Li B, Ma T and Cao Z: Multifunctional DNA nanosphere platform for real-time monitoring and fluorescence imaging-guided photodynamic therapy. Sensors and Actuators B: Chemical. 399:1347192024. View Article : Google Scholar : PubMed/NCBI | |
|
Buytaert E, Dewaele M and Agostinis P: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta. 1776:86–107. 2007.PubMed/NCBI | |
|
Ortel B, Shea CR and Calzavara-Pinton P: Molecular mechanisms of photodynamic therapy. Front Biosci (Landmark Ed). 14:4157–4172. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
He C, Xia J, Gao Y, Chen Z and Wan X: Chlorin A-mediated photodynamic therapy induced apoptosis in human cholangiocarcinoma cells via impaired autophagy flux. Am J Transl Res. 12:5080–5094. 2020.PubMed/NCBI | |
|
Casini A, Leone S, Vaccaro R, Vivacqua G, Ceci L, Pannarale L, Franchitto A, Onori P, Gaudio E and Mancinelli R: The emerging role of ferroptosis in liver cancers. Life (Basel). 12:21282022.PubMed/NCBI | |
|
Zhang ZJ, Huang YP, Li XX, Liu ZT, Liu K, Deng XF, Xiong L, Zou H and Wen Y: A novel ferroptosis-related 4-gene prognostic signature for cholangiocarcinoma and photodynamic therapy. Front Oncol. 11:7474452021. View Article : Google Scholar : PubMed/NCBI | |
|
Preise D, Scherz A and Salomon Y: Antitumor immunity promoted by vascular occluding therapy: Lessons from vascular-targeted photodynamic therapy (VTP). Photochem Photobiol Sci. 10:681–688. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD, Hoopes PJ and Pogue BW: Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int J Cancer. 123:695–701. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Deng F, Zheng R, Chen X, Zhao L, Yu B, Chen A, Jiang X, Cheng H and Li S: Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy. J Colloid Interface Sci. 612:562–571. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Wang G, Chen Y, Wang H, Hua Y and Cai Z: Immunogenic cell death in cancer therapy: Present and emerging inducers. J Cell Mol Med. 23:4854–4865. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Correia JH, Rodrigues JA, Pimenta S, Dong T and Yang Z: Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics. 13:13322021. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, et al: Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun. 10:33492019. View Article : Google Scholar : PubMed/NCBI | |
|
Liao S, Wang Y, Li Z, Zhang Y, Yin X, Huan S, Zhang XB, Liu S and Song G: A novel afterglow nanoreporter for monitoring cancer therapy. Theranostics. 12:6883–6897. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Ji B, Wei M and Yang B: Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics. 12:434–458. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M and Vauthey JN: Hilar cholangiocarcinoma: Expert consensus statement. HPB (Oxford). 17:691–699. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J and Wiedmann M: Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: Palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 244:230–239. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zoepf T, Jakobs R, Arnold JC, Apel D and Riemann JF: Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy. Am J Gastroenterol. 100:2426–2430. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen P, Yang T, Shi P, Shen J, Feng Q and Su J: Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis. Photodiagnosis Photodyn Ther. 37:1027122022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Xiong L, Liu W, Liu C, He C, Zou H, Wen Y and Lin L: SpyGlass-guided photodynamic therapy for unresectable cholangiocarcinoma: A case report and review of the literature. Front Oncol. 12:8907352022. View Article : Google Scholar : PubMed/NCBI | |
|
Lee TY, Cheon YK and Shim CS: Photodynamic therapy in patients with advanced hilar cholangiocarcinoma: Percutaneous cholangioscopic versus peroral transpapillary approach. Photomed Laser Surg. 34:150–156. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mukai T, Yasuda I, Nakashima M, Doi S, Iwashita T, Iwata K, Kato T, Tomita E and Moriwaki H: Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: A randomized controlled trial. J Hepatobiliary Pancreat Sci. 20:214–222. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee TY, Cheon YK, Shim CS and Cho YD: Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. World J Gastroenterol. 18:5589–5594. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bae BC, Yang SG, Jeong S, Lee DH, Na K, Kim JM, Costamagna G, Kozarek RA, Isayama H, Deviere J, et al: Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma. Biomaterials. 35:8487–8495. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liang PC, Huang KW, Tung CC, Chang MC, Chang FY, Wong JM and Chang YT: A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma. Biomed Microdevices. 20:32017. View Article : Google Scholar : PubMed/NCBI | |
|
Luvira V, Satitkarnmanee E, Pugkhem A, Kietpeerakool C, Lumbiganon P and Pattanittum P: Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database Syst Rev. 9:CD0128142021.PubMed/NCBI | |
|
Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, et al: Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 37:1015–1027. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T: Adjuvant photodynamic therapy for bile duct carcinoma after surgery: A preliminary study. J Gastroenterol. 39:1095–1101. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Jiang X, Xue P, Chen S, Li S, Li Z, Pan W and Zhang D: Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma. Photodiagnosis Photodyn Ther. 40:1031222022. View Article : Google Scholar : PubMed/NCBI | |
|
Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J and Witzigmann H: Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A phase II pilot study. Cancer. 97:2783–2790. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wagner A, Wiedmann M, Tannapfel A, Mayr C, Kiesslich T, Wolkersdörfer GW, Berr F, Hauss J and Witzigmann H: Neoadjuvant down-sizing of hilar cholangiocarcinoma with photodynamic therapy-long-term outcome of a phase II pilot study. Int J Mol Sci. 16:26619–2628. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cosgrove ND, Al-Osaimi AM, Sanoff HK, Morris MM, Read PW, Cox DG, Mann JA, Argo CK, Berg CL, Pelletier SJ, et al: Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation. Am J Transplant. 14:466–471. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kiesslich T, Wolkersdörfer G, Neureiter D, Salmhofer H and Berr F: Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci. 8:23–30. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fayter D, Corbett M, Heirs M, Fox D and Eastwood A: A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess. 14:1–288. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bartusik-Aebisher D, Osuchowski M, Adamczyk M, Stopa J, Cieślar G, Kawczyk-Krupka A and Aebisher D: Advancements in photodynamic therapy of esophageal cancer. Front Oncol. 12:10245762022. View Article : Google Scholar : PubMed/NCBI | |
|
Wu H, Minamide T and Yano T: Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc. 31:508–516. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zaar O, Fougelberg J, Hermansson A, Gillstedt M, Wennberg-Larkö AM and Paoli J: Effectiveness of photodynamic therapy in Bowen's disease: A retrospective observational study in 423 lesions. J Eur Acad Dermatol Venereol. 31:1289–1294. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Konopka K and Goslinski T: Photodynamic therapy in dentistry. J Dent Res. 86:694–707. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hopper C: Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol. 1:212–219. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Eckel F and Schmid RM: Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials. Br J Cancer. 96:896–902. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, Nagino M, Kondo S, Nagaoka S, Funai J, et al: Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: A comparative multicentre study in Japan. Br J Cancer. 103:469–474. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Li J, Yao L and Wu L: Effect of photodynamic therapy on gemcitabine-resistant cholangiocarcinoma in vitro and in vivo Through KLF10 and EGFR. Front Cell Dev Biol. 9:7107212021. View Article : Google Scholar : PubMed/NCBI | |
|
Gonzalez-Carmona MA, Bolch M, Jansen C, Vogt A, Sampels M, Mohr RU, van Beekum K, Mahn R, Praktiknjo M, Nattermann J, et al: Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma. Aliment Pharmacol Ther. 49:437–447. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Park DH, Lee SS, Park SE, Lee JL, Choi JH, Choi HJ, Jang JW, Kim HJ, Eum JB, Seo DW, et al: Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma. Eur J Cancer. 50:1259–1268. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Wang N, Wang Y, Shi Q, Yu R, Gu B, Maswikiti EP and Chen H: Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 41:1033182023. View Article : Google Scholar : PubMed/NCBI | |
|
Hong MJ, Cheon YK, Lee EJ, Lee TY and Shim CS: Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma. Gut Liver. 8:318–323. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Long K, Kang W, Wang T and Wang W: Optochemical control of immune checkpoint blockade via light-triggered PD-L1 Dimerization. Advance NanoBioMed Research. 2:2200017. 2022. | |
|
Bao R, Wang Y, Lai J, Zhu H, Zhao Y, Li S, Li N, Huang J, Yang Z, Wang F and Liu Z: Enhancing anti-PD-1/PD-L1 immune checkpoint inhibitory cancer therapy by CD276-targeted photodynamic ablation of tumor cells and tumor vascu lature. Mol Pharm. 16:339–348. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Brackett CM and Gollnick SO: Photodynamic therapy enhancement of anti-tumor immunity. Photochem Photobiol Sci. 10:649–652. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gu X, Wu B, Feng G, Chen Z, Re F, Che X, Hong W and Li W: PD-L1 blockade peptide-modified polymeric nanoparticles for oxygen-independent-based hypoxic tumor photo/thermodynamic immunotherapy. Mol Pharm. 20:4007–4020. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A and Hatfield AW: Photodynamic therapy for cancer of the pancreas. Gut. 50:549–557. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Verigos K, Stripp DCH, Mick R, Zhu TC, Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA, et al: Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol. 25:373–387. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W and Baumgartner R: Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med. 39:386–393. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Karakullukcu B, van Veen RL, Aans JB, Hamming-Vrieze O, Navran A, Teertstra HJ, van den Boom F, Niatsetski Y, Sterenborg HJ and Tan IB: MR and CT based treatment planning for mTHPC mediated interstitial photodynamic therapy of head and neck cancer: Description of the method. Lasers Surg Med. 45:517–523. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang AY and Yachimski PS: Endoscopic management of pancreatobiliary neoplasms. Gastroenterology. 154:1947–1963. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Soares KC, Kamel I, Cosgrove DP, Herman JM and Pawlik TM: Hilar cholangiocarcinoma: Diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 3:18–34. 2014.PubMed/NCBI | |
|
Coelho-Prabhu N and Baron TH: Endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholangiocarcinoma. Clin Liver Dis. 14:333–348. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Liu L, Wu JC, Bie LK and Gong B: Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis. Clin Res Hepatol Gastroenterol. 39:718–724. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Talreja JP and Kahaleh M: Photodynamic therapy for cholangiocarcinoma. Gut Liver. 4 (Suppl 1):S62–S66. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jung CFM, Lavole J, Barret M, Ali EA, Palmieri LJ, Dermine S, Barré A, Chaussade S and Coriat R: Local therapy in advanced cholangiocarcinoma: A review of current endoscopic, medical, and oncologic treatment options. Oncology. 97l:191–201. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mohan BP, Chandan S, Khan SR, Kassab LL, Ponnada S, Artifon ELA, Otoch JP, McDonough S and Adler DG: Photodynamic therapy (PDT), radiofrequency ablation (RFA) With biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J Clin Gastroenterol. 56:e153–e160. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Buerlein RCD and Wang AY: Endoscopic retrograde cholangiopancreatography-guided ablation for cholangiocarcinoma. Gastrointest Endosc Clin N Am. 29:351–367. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Killeen RP, Torreggiani WC, Malone DE and Brophy DP: Hemobilia as a potential complication in patients treated with photodynamic therapy for unresectable cholangiocarcinoma. Gastrointest Cancer Res. 3:802009.PubMed/NCBI |
